The univariate analysis showed that a positive ΔAUC was significantly associated with longer time to first SRE (p = 0.0002) and time to bone metastasis progression (p = 0.0012), suggesting that the persistence of RANK-positive CTCs predicted more favorable skeletal outcomes. The gene discussed is TNFRSF11A; the disease is bone metastasis.